Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Novan Inc (NOVN)

Novan Inc (NOVN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 166,818
  • Shares Outstanding, K 151,653
  • Annual Sales, $ 4,920 K
  • Annual Income, $ -29,290 K
  • 60-Month Beta -0.03
  • Price/Sales 36.68
  • Price/Cash Flow N/A
  • Price/Book 56.57
Trade NOVN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.17
  • Growth Rate Est. (year over year) +587,747.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0700 +2.80%
on 04/16/21
1.7300 -36.42%
on 03/18/21
-0.4900 (-30.82%)
since 03/16/21
3-Month
1.0700 +2.80%
on 04/16/21
2.5900 -57.53%
on 02/16/21
-0.1700 (-13.39%)
since 01/15/21
52-Week
0.3000 +266.67%
on 09/04/20
2.5900 -57.53%
on 02/16/21
+0.7141 (+185.05%)
since 04/16/20

Most Recent Stories

More News
Thinking about buying stock in Biocept, AbCellera Biologics, Novan, Seelos Therapeutics, or SRAX?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BIOC, ABCL, NOVN, SEEL, and SRAX.

ABCL : 29.82 (+2.83%)
NOVN : 1.1000 (-7.56%)
SEEL : 5.26 (-0.38%)
BIOC : 4.36 (-0.68%)
SRAX : 4.19 (-4.34%)
Pharming Group announces the intention to nominate three Non-Executive Directors to the Board of Directors

LEIDEN, Netherlands, March 23, 2021 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces the intention to nominate Steven Baert, Leon Kruimer...

PHGUF : 1.2500 (-3.85%)
PHAR : 13.07 (-3.76%)
NOVN : 1.1000 (-7.56%)
ONCY : 2.99 (+2.05%)
ADP : 192.94 (+0.55%)
Thinking about buying stock in Invo Bioscience, Norwegian Cruise Line, Novan, Altimmune, or Transocean?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for INVO, NCLH, NOVN, ALT, and RIG.

ALT : 12.27 (-3.61%)
INVO : 3.77 (-2.08%)
NOVN : 1.1000 (-7.56%)
NCLH : 28.32 (+0.14%)
RIG : 3.42 (+0.29%)
Thinking about buying stock in Moderna, Nio, Pfizer, Novan, or Surface Oncology?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRNA, NIO, PFE, NOVN, and SURF.

MRNA : 170.81 (+6.84%)
NOVN : 1.1000 (-7.56%)
SURF : 6.79 (-5.17%)
NIO : 36.09 (+1.21%)
PFE : 38.57 (+2.58%)
Thinking about buying stock in OpGen, XpresSpa, Jaguar Health, Orchard Therapeutics, or Novan?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OPGN, XSPA, JAGX, ORTX, and NOVN.

NOVN : 1.1000 (-7.56%)
ORTX : 6.02 (-5.05%)
XSPA : 1.3600 (+0.74%)
JAGX : 1.3000 (-7.80%)
OPGN : 2.28 (-1.72%)
Novan to Present at the H.C. Wainwright Global Life Sciences Conference

Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, will present at the virtual H.C. Wainwright Global Life...

NOVN : 1.1000 (-7.56%)
Novan Bolsters Commercialization Expertise with Election of Steven D. Skolsky to Board of Directors

Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN), today announced the election of Steven D. Skolsky to its Board of Directors.

NOVN : 1.1000 (-7.56%)
Thinking about buying stock in Aslan Pharmaceuticals, electroCore, Novan, OpGen, or Salarius Pharmaceuticals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ASLN, ECOR, NOVN, OPGN, and SLRX.

ASLN : 3.01 (-2.59%)
ECOR : 1.7900 (+1.70%)
NOVN : 1.1000 (-7.56%)
SLRX : 1.1500 (-3.36%)
OPGN : 2.28 (-1.72%)
Noven Submits New Drug Application for Investigational Dextroamphetamine Transdermal System for ADHD

Noven Pharmaceuticals, Inc., ("Noven") a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today confirmed it has submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration...

HTSUF : 61.0000 (unch)
NOVN : 1.1000 (-7.56%)
Thinking about buying stock in Ampio Pharmaceuticals, Motus GI, Phio Pharmaceuticals, Novan, or Oncolytics Biotech?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMPE, MOTS, PHIO, NOVN, and ONCY.

AMPE : 1.5700 (unch)
MOTS : 0.9570 (-8.86%)
NOVN : 1.1000 (-7.56%)
ONCY : 2.99 (+2.05%)
PHIO : 2.29 (-1.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Novan, Inc. is a pharmaceutical company. It engaged in the development and commercialization of therapies using its nitric oxide platform for dermatology. The Company's product candidates primarily include SB204, SB206, SB208 and SB414 which are in pre-clinical trial stage. It develops product through...

See More

Key Turning Points

3rd Resistance Point 1.2067
2nd Resistance Point 1.1733
1st Resistance Point 1.1367
Last Price 1.1000
1st Support Level 1.0667
2nd Support Level 1.0333
3rd Support Level 0.9967

See More

52-Week High 2.5900
Fibonacci 61.8% 1.7152
Fibonacci 50% 1.4450
Fibonacci 38.2% 1.1748
Last Price 1.1000
52-Week Low 0.3000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar